Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
- T47.5X6ABillable
Underdosing of digestants, initial encounter
- T47.5X6DBillable
Underdosing of digestants, subsequent encounter
- T47.5X6SBillable
Underdosing of digestants, sequela
- T47.6X5ABillable
Adverse effect of antidiarrheal drugs, initial encounter
- T47.6X5DBillable
Adverse effect of antidiarrheal drugs, subsequent encounter
- T47.6X5SBillable
Adverse effect of antidiarrheal drugs, sequela
- T47.6X6ABillable
Underdosing of antidiarrheal drugs, initial encounter
- T47.6X6DBillable
Underdosing of antidiarrheal drugs, subsequent encounter
- T47.6X6SBillable
Underdosing of antidiarrheal drugs, sequela
- T47.7X5ABillable
Adverse effect of emetics, initial encounter
- T47.7X5DBillable
Adverse effect of emetics, subsequent encounter
- T47.7X5SBillable
Adverse effect of emetics, sequela
- T47.7X6ABillable
Underdosing of emetics, initial encounter
- T47.7X6DBillable
Underdosing of emetics, subsequent encounter
- T47.7X6SBillable
Underdosing of emetics, sequela
- T47.8X5ABillable
Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
- T47.8X5DBillable
Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
- T47.8X5SBillable
Adverse effect of other agents primarily affecting gastrointestinal system, sequela
- T47.8X6ABillable
Underdosing of other agents primarily affecting gastrointestinal system, initial encounter
- T47.8X6DBillable
Underdosing of other agents primarily affecting gastrointestinal system, subsequent encounter
- T47.8X6SBillable
Underdosing of other agents primarily affecting gastrointestinal system, sequela
- T47.95XABillable
Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
- T47.95XDBillable
Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
- T47.95XSBillable
Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
- T47.96XABillable
Underdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounter
- T47.96XDBillable
Underdosing of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
- T47.96XSBillable
Underdosing of unspecified agents primarily affecting the gastrointestinal system, sequela
- T48.0X5ABillable
Adverse effect of oxytocic drugs, initial encounter
- T48.0X5DBillable
Adverse effect of oxytocic drugs, subsequent encounter
- T48.0X5SBillable
Adverse effect of oxytocic drugs, sequela
- T48.0X6ABillable
Underdosing of oxytocic drugs, initial encounter
- T48.0X6DBillable
Underdosing of oxytocic drugs, subsequent encounter
- T48.0X6SBillable
Underdosing of oxytocic drugs, sequela
- T48.1X5ABillable
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
- T48.1X5DBillable
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
- T48.1X5SBillable
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
- T48.1X6ABillable
Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
- T48.1X6DBillable
Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
- T48.1X6SBillable
Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], sequela
- T48.205ABillable
Adverse effect of unspecified drugs acting on muscles, initial encounter
- T48.205DBillable
Adverse effect of unspecified drugs acting on muscles, subsequent encounter
- T48.205SBillable
Adverse effect of unspecified drugs acting on muscles, sequela
- T48.206ABillable
Underdosing of unspecified drugs acting on muscles, initial encounter
- T48.206DBillable
Underdosing of unspecified drugs acting on muscles, subsequent encounter
- T48.206SBillable
Underdosing of unspecified drugs acting on muscles, sequela
- T48.295ABillable
Adverse effect of other drugs acting on muscles, initial encounter
- T48.295DBillable
Adverse effect of other drugs acting on muscles, subsequent encounter
- T48.295SBillable
Adverse effect of other drugs acting on muscles, sequela
- T48.296ABillable
Underdosing of other drugs acting on muscles, initial encounter
- T48.296DBillable
Underdosing of other drugs acting on muscles, subsequent encounter
- T48.296SBillable
Underdosing of other drugs acting on muscles, sequela
- T48.3X5ABillable
Adverse effect of antitussives, initial encounter
- T48.3X5DBillable
Adverse effect of antitussives, subsequent encounter
- T48.3X5SBillable
Adverse effect of antitussives, sequela
- T48.3X6ABillable
Underdosing of antitussives, initial encounter
- T48.3X6DBillable
Underdosing of antitussives, subsequent encounter
- T48.3X6SBillable
Underdosing of antitussives, sequela
- T48.4X5ABillable
Adverse effect of expectorants, initial encounter
- T48.4X5DBillable
Adverse effect of expectorants, subsequent encounter
- T48.4X5SBillable
Adverse effect of expectorants, sequela
- T48.4X6ABillable
Underdosing of expectorants, initial encounter
- T48.4X6DBillable
Underdosing of expectorants, subsequent encounter
- T48.4X6SBillable
Underdosing of expectorants, sequela
- T48.5X5ABillable
Adverse effect of other anti-common-cold drugs, initial encounter
- T48.5X5DBillable
Adverse effect of other anti-common-cold drugs, subsequent encounter
- T48.5X5SBillable
Adverse effect of other anti-common-cold drugs, sequela
- T48.5X6ABillable
Underdosing of other anti-common-cold drugs, initial encounter
- T48.5X6DBillable
Underdosing of other anti-common-cold drugs, subsequent encounter
- T48.5X6SBillable
Underdosing of other anti-common-cold drugs, sequela
- T48.6X5ABillable
Adverse effect of antiasthmatics, initial encounter
- T48.6X5DBillable
Adverse effect of antiasthmatics, subsequent encounter
- T48.6X5SBillable
Adverse effect of antiasthmatics, sequela
- T48.6X6ABillable
Underdosing of antiasthmatics, initial encounter
- T48.6X6DBillable
Underdosing of antiasthmatics, subsequent encounter
- T48.6X6SBillable
Underdosing of antiasthmatics, sequela
- T48.905ABillable
Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
- T48.905DBillable
Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter
- T48.905SBillable
Adverse effect of unspecified agents primarily acting on the respiratory system, sequela
- T48.906ABillable
Underdosing of unspecified agents primarily acting on the respiratory system, initial encounter
- T48.906DBillable
Underdosing of unspecified agents primarily acting on the respiratory system, subsequent encounter
- T48.906SBillable
Underdosing of unspecified agents primarily acting on the respiratory system, sequela
- T48.995ABillable
Adverse effect of other agents primarily acting on the respiratory system, initial encounter
- T48.995DBillable
Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter
- T48.995SBillable
Adverse effect of other agents primarily acting on the respiratory system, sequela
- T48.996ABillable
Underdosing of other agents primarily acting on the respiratory system, initial encounter
- T48.996DBillable
Underdosing of other agents primarily acting on the respiratory system, subsequent encounter
- T48.996SBillable
Underdosing of other agents primarily acting on the respiratory system, sequela
- T49.0X5ABillable
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
- T49.0X5DBillable
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
- T49.0X5SBillable
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
- T49.0X6ABillable
Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
- T49.0X6DBillable
Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
- T49.0X6SBillable
Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, sequela
- T49.1X5ABillable
Adverse effect of antipruritics, initial encounter
- T49.1X5DBillable
Adverse effect of antipruritics, subsequent encounter
- T49.1X5SBillable
Adverse effect of antipruritics, sequela
- T49.1X6ABillable
Underdosing of antipruritics, initial encounter
- T49.1X6DBillable
Underdosing of antipruritics, subsequent encounter
- T49.1X6SBillable
Underdosing of antipruritics, sequela
- T49.2X5ABillable
Adverse effect of local astringents and local detergents, initial encounter
